Stopping rules employing response rates, time to progression, and early progressive disease for phase II oncology trials.
about
Stopping rules employing response rates, time to progression, and early progressive disease for phase II oncology trials.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Stopping rules employing respo ...... for phase II oncology trials.
@ast
Stopping rules employing respo ...... for phase II oncology trials.
@en
Stopping rules employing respo ...... for phase II oncology trials.
@nl
type
label
Stopping rules employing respo ...... for phase II oncology trials.
@ast
Stopping rules employing respo ...... for phase II oncology trials.
@en
Stopping rules employing respo ...... for phase II oncology trials.
@nl
prefLabel
Stopping rules employing respo ...... for phase II oncology trials.
@ast
Stopping rules employing respo ...... for phase II oncology trials.
@en
Stopping rules employing respo ...... for phase II oncology trials.
@nl
P2860
P356
P1476
Stopping rules employing respo ...... for phase II oncology trials.
@en
P2093
Greg R Pond
John R Goffin
P2860
P2888
P356
10.1186/1471-2288-11-164
P577
2011-12-12T00:00:00Z
P5875
P6179
1013901124